National Pension Service’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-14
Closed -$2.77K 512
2023
Q1
$2.77K Sell
14
-4,341
-100% -$984K ﹤0.01% 509
2022
Q4
$949K Hold
4,355
﹤0.01% 487
2022
Q3
$827K Hold
4,355
﹤0.01% 501
2022
Q2
$932K Buy
4,355
+555
+15% +$136K ﹤0.01% 492
2022
Q1
$1.08M Sell
3,800
-76,600
-95% -$23.6M ﹤0.01% 477
2021
Q4
$30.3M Buy
80,400
+76,600
+2,016% +$29.8M 0.05% 407
2021
Q3
$1.57M Buy
+3,800
New +$1.58M ﹤0.01% 469

Other funds holding CRL

National Pension Service's CRL Position: Q2 2023 in Review

National Pension Service sold out of Charles River Laboratories (CRL) in Q2 2023, closing a stake of 14 shares — an estimated $2.77K sold.

National Pension Service first reported a position in CRL in Q3 2021 and held it in 7 quarters. The position peaked at $30.3M in Q4 2021. 612 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

  • National Pension Service reported no remaining Charles River Laboratories position as of Q2 2023 after selling out during the quarter.
  • National Pension Service sold 14 Charles River Laboratories shares in Q2 2023, an estimated $2.77K.
  • National Pension Service first reported a position in Charles River Laboratories in Q3 2021 and held it in 7 quarters.
  • National Pension Service's Charles River Laboratories position peaked at $30.3M in Q4 2021.
  • 612 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on National Pension Service's 13F filing for Q2 2023, filed 16 Aug 2023.